Dr. Juan P. Casas, a physician epidemiologist, led the study, which called for prioritizing clinical trials of drugs targeting two proteins.
Credit
Frank Curran
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.